Patient Decision Aid for Acute Coronary Syndrome
(BETA-DAPT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a tool designed to help patients with acute coronary syndrome make informed decisions about their antiplatelet therapy. It focuses on patients at high risk of both bleeding and blood clots after receiving heart stents. The tool, known as the Patient Decision Aid, guides these patients and their doctors in choosing the best treatment strategy by weighing the benefits and risks of different therapies. Patients hospitalized at the Montreal Heart Institute who have recently undergone heart procedures might be suitable candidates. The goal is to evaluate how well this decision-making aid performs in real-world situations. As an unphased trial, this study offers patients the opportunity to contribute to innovative research that could enhance decision-making for future heart patients.
What prior data suggests that this patient decision aid is safe for use in shared decision-making?
Research shows that using a patient decision aid (PDA) is generally safe. In other studies with different patient groups, PDAs have been well-received. For example, a study on a decision aid for people with chest pain found that it increased their knowledge without any safety issues. Another study found that using a decision aid improved how involved and satisfied patients felt.
The PDA in this trial is not a drug or medical procedure but a tool to help patients and doctors make decisions together. It does not have physical side effects like a medication might. The goal is to improve understanding and decision-making, which can lead to better health outcomes.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it introduces the Patient Decision Aid (PDA) to enhance decision-making for patients with acute coronary syndrome (ACS) undergoing complex percutaneous coronary intervention (PCI). Unlike traditional treatments that focus solely on medical procedures and medications, this approach emphasizes shared decision-making between patients and clinicians. By using the PDA, the trial aims to improve the quality of decisions by ensuring patients are fully informed and involved in their treatment choices, potentially leading to better outcomes and patient satisfaction.
What evidence suggests that this patient decision aid is effective for acute coronary syndrome?
Research shows that decision aids help patients understand their treatment options and associated risks. Studies have found that these tools enhance patient knowledge about their health condition and available treatment choices. In cases of acute coronary syndrome (ACS), understanding the balance between bleeding and clotting risks is crucial when selecting a dual antiplatelet therapy (DAPT) plan. This trial will use a Patient Decision Aid (PDA) to support shared decision-making between patients and clinicians after PCI. Previous decision aids have increased patient understanding and ensured that treatment choices align with patient values. This tool aims to achieve the same by supporting shared decision-making, which has improved decision quality.15678
Are You a Good Fit for This Trial?
This trial is for patients who have had a heart attack and received stent placement, are at high risk of bleeding, and also face a high chance of blood clots. It's designed to help them choose the best strategy for taking blood-thinning medications with their doctors.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Beta Testing
Real-world testing of the Patient Decision Aid (PDA) with the target population and clinicians to evaluate usability and acceptability
Follow-up
Participants are monitored for decision-making preparedness and usability of the PDA
Post-Discharge Monitoring
Monitoring of agreement between patient-preferred antiplatelet strategy and strategy prescribed at hospital discharge
What Are the Treatments Tested in This Trial?
Interventions
- Patient Decision Aid
Trial Overview
The study tests a patient decision aid tool that helps those at dual risk after heart procedures understand their medication options, risks, and benefits to make informed choices about their treatment together with clinicians.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
The intervention is the use of the Patient Decision Aid (PDA) to support shared decision-making between patients and clinicians after PCI, assessed using questionnaires capturing multiple dimensions of decision quality. No pharmacologic treatment is administered as part of the study; exposure consists solely of complete use of the PDA according to the protocol. The study includes a single pre-post group, no interim analyses are planned given the limited project duration, and a single beta-testing phase will be conducted.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montreal Heart Institute
Lead Sponsor
Citations
Effectiveness of the Chest Pain Choice Decision Aid in ...
We will measure the effect of CPC on (1) patient knowledge regarding their 45-day risk for ACS and the available management options (primary ...
The Chest Pain Choice Decision Aid: A Randomized Trial
The decision aid included a 100-person pictograph depicting the pretest probability of acute coronary syndrome and available management options ...
Shared decision making in patients with low risk chest pain
The primary outcome, selected by patient and caregiver advisers, was patient knowledge of their risk for acute coronary syndrome and options for ...
DAPT Strategy in HBR Patients Undergoing Complex PCI ...
Patient decision aid to support shared decision-making between patients and clinicians by helping patients understand their risks, available ...
Testing a Decision Aid for Patients with Low-Risk Chest ...
Over the past decade, the proportion of patients diagnosed with acute coronary syndrome (ACS) in the emergency setting decreased from 26% to 13%. Despite the ...
Testing a Decision Aid for Patients with Low-Risk Chest Pain ...
We compared the effectiveness of shared decision-making facilitated by the Chest Pain Choice (CPC) decision aid with usual care (UC) in the choice of admission ...
Impact of a Shared Decision Making Intervention on Health ...
Conclusions Use of a decision aid in patients at low risk for acute coronary syndrome increased patient knowledge about their risk, increased engagement ...
Shared Decision-Making and Cardiovascular Health
Using decision aids that calculate individual risk for CVD may improve patient engagement and satisfaction and reduce decisional regret. For the best outcomes, ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.